CNM-Au8 prolonged survival for people with ALS relative to those who received the investigational treatment zilucoplan or a ...

Holly Turner, 45, first started to feel a twitch in her leg four years ago when she was caring for her late sister, 50, who ...

在研究结论与讨论部分，此次研究表明，ALS 患者在疾病早期就存在视觉空间能力的损伤，涉及感知和表征能力。这一发现提示，仅依赖标准筛查工具评估基本视觉感知技能，可能会低估 ALS 患者视觉空间缺陷的程度，忽略与后皮质萎缩相关的视觉空间缺陷，而后皮质萎缩与 ALS ...

Patients with ALS often lose their ability to speak making it harder to communicate with their family. This AI-powered device ...

2025年2月24日， 北京大学第三医院（以下简称“北医三院”）神经内科樊东升教授团队在权威期刊、JAMA杂志子刊JAMA Network Open上发表了题为“Tetramethylpyrazine Nitrone in Amyotrophic ...

现有的转基因动物模型，大多只能聚焦于 TDP-43 蛋白病的晚期阶段，对于疾病早期、症状出现前的运动神经元特异性病理变化，却无能为力。就好比我们只能看到疾病发展的 “果”，却难以探寻其 “因”。为了填补这一空白，深入了解疾病的早期进程，来自美国休斯顿卫理公会研究所（Houston Methodist Research ...

Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.

Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...

The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...